U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
111391111391VISIONAIREâ„¢ Value StudyCompletedNo Results AvailableOsteoarthritis of the Kneehttps://ClinicalTrials.gov/show/NCT01107769
111392111392A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based RegimenCompletedNo Results AvailableNeoplasms (no Otherwise Specified)Drug: LENOGRASTIM (GRANOGYTE 34)https://ClinicalTrials.gov/show/NCT01107756
111393111393Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)CompletedHas ResultsHypertension|Angina Pectoris|Hypercholesterolemia|Familial HypercholesterolemiaDrug: Amlodipine/Atorvastatinhttps://ClinicalTrials.gov/show/NCT01107743
111394111394Vitamin C for Prophylaxis of Post-operative Atrial Fibrillation in On-pump Cardiac Surgery ProceduresCompletedHas ResultsAtrial FibrillationDrug: Vitamin C|Drug: L-Carnitine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01107730
111395111395Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DMRecruitingNo Results AvailableDiabetesDrug: metformin\pioglitazone\exenatide|Drug: metformin, glyburide and glarginehttps://ClinicalTrials.gov/show/NCT01107717
111396111396Family Support Intervention in Intensive Care Units (The Four Supports Study)CompletedNo Results AvailablePhysician-Family Communication in Intensive Care Units|Surrogate Decision-making for Critically Ill PatientsBehavioral: Family Support Interventionhttps://ClinicalTrials.gov/show/NCT01107704
111397111397Comparison of 1 vs 3 Sets of Resistance Training on Muscular HypertrophyCompletedNo Results AvailableObesityOther: Amount of resistance offered in traininghttps://ClinicalTrials.gov/show/NCT01107691
111398111398YMCA-Physical Activity and NutritionCompletedNo Results AvailableChildhood ObesityOther: Healthy Snacks and Organized Physical Activityhttps://ClinicalTrials.gov/show/NCT01107678
111399111399Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV MelanomaRecruitingNo Results AvailableStage III Melanoma|Stage IV Melanoma|Unresectable MelanomaDrug: Pazopanib and Paclitaxelhttps://ClinicalTrials.gov/show/NCT01107665
111400111400Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryActive, not recruitingNo Results AvailableAdenocarcinoma of the Gastroesophageal Junction|Esophageal CancerBiological: cetuximab|Drug: cisplatin|Drug: docetaxel|Procedure: adjuvant therapy|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT01107639
111401111401Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung CancerRecruitingNo Results AvailableLung CancerBiological: bevacizumab|Drug: pemetrexed disodiumhttps://ClinicalTrials.gov/show/NCT01107626
111402111402The Role of Opinion Leaders in Enhancing Evidence-based Care After Chronic Obstructive Pulmonary Disease (COPD) Emergency Department (ED) VisitsNot yet recruitingNo Results AvailableChronic Obstructive Pulmonary DiseaseOther: Opinion leader educational letterhttps://ClinicalTrials.gov/show/NCT01107613
111403111403Study on Immediate Loading of Immediately Placed Single Implants.Not yet recruitingNo Results AvailableDental ImplantsProcedure: Immediate implant and socket preservationhttps://ClinicalTrials.gov/show/NCT01107600
111404111404Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy InfantsCompletedNo Results AvailableRotavirus GastroenteritisBiological: GSK Biologicals' human rotavirus vaccine 444563|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01107587
111405111405Fibromyalgia Treatment Trial With Gabapentin and Osteopathic Manipulative MedicineCompletedNo Results AvailableFibromyalgiaDrug: Gabapentin|Procedure: Osteopathic Manipulative Medicine|Other: Gabapentin and Osteopathic Manipulative Medicinehttps://ClinicalTrials.gov/show/NCT01107574
111406111406Different Techniques for Emergency CricothyroidotomyCompletedNo Results AvailableIntubation, IntratrachealOther: Seldinger technique|Device: Surgical Airway Approachhttps://ClinicalTrials.gov/show/NCT01107561
111407111407Prevention of Stroke and Dementia in Primary CareTerminatedNo Results AvailableStroke|Dementia|DisabilityOther: Systematic detection of vascular risk factors and subsequent evidence-based treatmenthttps://ClinicalTrials.gov/show/NCT01107548
111408111408Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) InfectionCompletedHas ResultsRespiratory Syncytial Virus InfectionBiological: Synagis (palivizumab), monoclonal antibody for passive immunoprophylaxis against severe RSV disease administered according to usual clinical practice.https://ClinicalTrials.gov/show/NCT01107535
111409111409Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and RecruitingNo Results AvailableSolid Tumors, Glioblastoma, Recurrent Malignant GliomasDrug: CTO|Drug: CTO and Temodar®|Drug: CTO, Temodar®, Radiation therapyhttps://ClinicalTrials.gov/show/NCT01107522
111410111410Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of BiomarkersActive, not recruitingNo Results AvailableCarcinoma, Renal CellDrug: everolimushttps://ClinicalTrials.gov/show/NCT01107509
111411111411A Phase I/IIa, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Safety, and Efficacy of SPN-812V in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNo Results AvailableADHDDrug: SPN-812V|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01107496
111412111412Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) InfectionCompletedNo Results AvailableHepatitis B, Chronichttps://ClinicalTrials.gov/show/NCT01107483
111413111413Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in ARTRecruitingNo Results AvailableInfertilityDrug: hFSH(Fostimon)|Drug: hFSH(Fostimon)|Drug: hFSH(Fostimon)|Drug: hFSH(Fostimon)https://ClinicalTrials.gov/show/NCT01107470
111414111414A Study in Participants With Moderate to Severe PsoriasisActive, not recruitingNo Results AvailablePsoriasisBiological: ixekizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01107457
111415111415Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung CancerCompletedNo Results AvailableNon Small Cell Lung CancerDrug: Docetaxel|Drug: LY2181308https://ClinicalTrials.gov/show/NCT01107444
111416111416Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and InsulinCompletedNo Results AvailablePre-diabetesDietary Supplement: L-Arabinose and Chromium|Dietary Supplement: Sucrose without dietary Supplementhttps://ClinicalTrials.gov/show/NCT01107431
111417111417A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic MelanomaCompletedHas ResultsMalignant MelanomaDrug: RO5185426|Drug: RO5185426|Drug: RO5185426|Drug: RO5185426|Drug: RO5185426https://ClinicalTrials.gov/show/NCT01107418
111418111418Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen ChallengeCompletedHas ResultsAllergic ConjunctivitisDrug: Loteprednol etabonate base (QD)|Drug: Loteprednol etabonate base (BID)|Drug: Loteprednol etabonate base (QID)|Drug: Loteprednol etabonate suspension|Drug: Vehicle of loteprednol etabonatehttps://ClinicalTrials.gov/show/NCT01107405
111419111419Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaCompletedHas ResultsBenign Prostatic HyperplasiaDrug: botulinum toxin Type A|Drug: Normal salinehttps://ClinicalTrials.gov/show/NCT01107392
111420111420Optimization and Refinement of Technique in In-Office Sinus Dilation 2CompletedHas ResultsSinusitisDevice: Relieva Balloon Sinuplasty Systemhttps://ClinicalTrials.gov/show/NCT01107379

* Görseller ve İçerik tekif hakkına sahip olabilir